Arcus Biosciences, Inc. Diluted Shares Outstanding (Weighted Average)
Arcus Biosciences, Inc. (RCUS) reported Diluted Shares Outstanding (Weighted Average) of 126.10 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-05
- Arcus Biosciences, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 126.10M shares, a 18.40% increase year-over-year.
- Arcus Biosciences, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 125.40M shares, a 27.44% increase year-over-year.
- Arcus Biosciences, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 118.50M shares, a 29.37% increase year-over-year.
- Arcus Biosciences, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 106.50M shares, a 16.52% increase year-over-year.
- Arcus Biosciences, Inc. weighted average number of shares outstanding, diluted for fiscal 2025 was 107.40M shares, a 19.20% increase from fiscal 2024.
- Arcus Biosciences, Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 90.10M shares, a 21.76% increase from fiscal 2023.
- Arcus Biosciences, Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 74.00M shares, a 2.78% increase from fiscal 2022.
- Arcus Biosciences, Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 72.00M shares, a 2.70% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 126.10M shares 10-Q · filed 2026-08-05 | 125.70M shares 10-Q · filed 2026-08-05 | 123.33M shares derived: average of 3 quarters · filed 2026-08-05 | 119.13M shares derived: average of 4 quarters · filed 2026-08-05 | |||
| 2026-03-31 | 125.40M shares 10-Q · filed 2026-05-05 | 121.95M shares derived: average of 2 quarters · filed 2026-05-05 | 116.80M shares derived: average of 3 quarters · filed 2026-05-05 | 114.22M shares derived: average of 4 quarters · filed 2026-08-05 | |||
| 2025-12-31 | 118.50M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | 112.50M shares derived: average of 2 quarters · filed 2026-02-25 | 110.50M shares derived: average of 3 quarters · filed 2026-08-05 | 107.40M shares 10-K · filed 2026-02-25 | |||
| 2025-09-30 | 106.50M shares 10-Q · filed 2025-10-28 | 106.50M shares derived: average of 2 quarters · filed 2026-08-05 | 103.70M shares 10-Q · filed 2025-10-28 | 100.75M shares derived: average of 4 quarters · filed 2026-08-05 | |||
| 2025-06-30 | 106.50M shares 10-Q · filed 2026-08-05 | 102.30M shares 10-Q · filed 2026-08-05 | 98.83M shares derived: average of 3 quarters · filed 2026-08-05 | 96.97M shares derived: average of 4 quarters · filed 2026-08-05 | |||
| 2025-03-31 | 98.40M shares 10-Q · filed 2026-05-05 | 95.00M shares derived: average of 2 quarters · filed 2026-05-05 | 93.80M shares derived: average of 3 quarters · filed 2026-05-05 | 93.13M shares derived: average of 4 quarters · filed 2026-05-05 | |||
| 2024-12-31 | 91.60M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | 91.50M shares derived: average of 2 quarters · filed 2026-02-25 | 91.37M shares derived: average of 3 quarters · filed 2026-02-25 | 90.10M shares 10-K · filed 2026-02-25 | |||
| 2024-09-30 | 91.40M shares 10-Q · filed 2025-10-28 | 91.25M shares derived: average of 2 quarters · filed 2025-10-28 | 89.60M shares 10-Q · filed 2025-10-28 | 85.97M shares derived: average of 4 quarters · filed 2026-02-25 | |||
| 2024-06-30 | 91.10M shares 10-Q · filed 2025-08-06 | 88.60M shares 10-Q · filed 2025-08-06 | 84.17M shares derived: average of 3 quarters · filed 2026-02-25 | 81.78M shares derived: average of 4 quarters · filed 2026-02-25 | |||
| 2024-03-31 | 86.20M shares 10-Q · filed 2025-05-06 | 80.70M shares derived: average of 2 quarters · filed 2026-02-25 | 78.67M shares derived: average of 3 quarters · filed 2026-02-25 | 77.30M shares derived: average of 4 quarters · filed 2026-02-25 | |||
| 2023-12-31 | 75.20M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | 74.90M shares derived: average of 2 quarters · filed 2026-02-25 | 74.33M shares derived: average of 3 quarters · filed 2026-02-25 | 74.00M shares 10-K · filed 2026-02-25 | |||
| 2023-09-30 | 74.60M shares 10-Q · filed 2024-11-06 | 73.90M shares derived: average of 2 quarters · filed 2024-11-06 | 73.60M shares 10-Q · filed 2024-11-06 | 73.35M shares derived: average of 4 quarters · filed 2025-02-25 | |||
| 2023-06-30 | 73.20M shares 10-Q · filed 2024-08-08 | 73.10M shares 10-Q · filed 2024-08-08 | 72.93M shares derived: average of 3 quarters · filed 2025-02-25 | 72.75M shares derived: average of 4 quarters · filed 2025-02-25 | |||
| 2023-03-31 | 73.00M shares 10-Q · filed 2024-05-08 | 72.80M shares derived: average of 2 quarters · filed 2025-02-25 | 72.60M shares derived: average of 3 quarters · filed 2025-02-25 | 72.40M shares derived: average of 4 quarters · filed 2025-02-25 | |||
| 2022-12-31 | 72.60M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | 72.40M shares derived: average of 2 quarters · filed 2025-02-25 | 72.20M shares derived: average of 3 quarters · filed 2025-02-25 | 72.00M shares 10-K · filed 2025-02-25 | |||
| 2022-09-30 | 72.20M shares 10-Q · filed 2023-11-07 | 72.24M shares 10-Q · filed 2022-11-02 | 72.00M shares derived: average of 2 quarters · filed 2023-11-07 | 71.80M shares 10-Q · filed 2023-11-07 | 71.75M shares 10-Q · filed 2022-11-02 | 76.06M shares derived: average of 4 quarters · filed 2024-02-21 | |
| 2022-06-30 | 71.80M shares 10-Q · filed 2023-08-07 | 71.50M shares 10-Q · filed 2023-08-07 | 77.34M shares derived: average of 3 quarters · filed 2024-02-21 | 75.53M shares derived: average of 4 quarters · filed 2024-02-21 | |||
| 2022-03-31 | 71.20M shares 10-Q · filed 2023-05-09 | 80.11M shares derived: average of 2 quarters · filed 2024-02-21 | 76.78M shares derived: average of 3 quarters · filed 2024-02-21 | ||||
| 2021-12-31 | 89.03M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | 79.57M shares derived: average of 2 quarters · filed 2024-02-21 | 74.00M shares 10-K · filed 2024-02-21 | 73.97M shares 10-K · filed 2022-02-23 | |||
| 2021-09-30 | 70.11M shares 10-Q · filed 2022-11-02 | 68.99M shares 10-Q · filed 2022-11-02 | |||||
| 2020-12-31 | 63.53M shares 10-K · filed 2021-02-25 | 64.34M shares derived: average of 2 quarters · filed 2021-11-08 | 59.08M shares derived: average of 3 quarters · filed 2021-11-08 | 54.80M shares 10-K · filed 2023-02-28 | 54.79M shares 10-K · filed 2022-02-23 | ||
| 2020-09-30 | 65.15M shares 10-Q · filed 2021-11-08 | 56.85M shares derived: average of 2 quarters · filed 2021-11-08 | 51.85M shares 10-Q · filed 2021-11-08 | 50.51M shares derived: average of 4 quarters · filed 2022-02-23 | |||
| 2020-06-30 | 48.56M shares 10-K · filed 2021-02-25 | 46.42M shares derived: average of 2 quarters · filed 2021-02-25 | 45.63M shares derived: average of 3 quarters · filed 2022-02-23 | 45.21M shares derived: average of 4 quarters · filed 2022-02-23 | |||
| 2020-03-31 | 44.28M shares 10-K · filed 2021-02-25 | 44.17M shares derived: average of 2 quarters · filed 2022-02-23 | 44.09M shares derived: average of 3 quarters · filed 2022-02-23 | ||||
| 2019-12-31 | 44.05M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | 44.00M shares derived: average of 2 quarters · filed 2022-02-23 | 43.83M shares 10-K · filed 2022-02-23 | ||||
| 2019-09-30 | 43.94M shares 10-Q · filed 2020-11-05 | 43.75M shares 10-Q · filed 2020-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |